ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Rallybio Corporation

Rallybio Corporation (RLYB)

15,85
-0,05
(-0,31%)
Beim Schlusskurs: 17 Juni 10:00PM
15,85
0,00
( 0,00% )
Nach Börsenschluss: 11:30PM

Rallybio Corporation (RLYB) Aktie

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
15,85
( -0,31% )
Gebot
15,81
Fragen
16,37
Volumen
20.105
15,77 Tagesbereich 16,02
0,30 52-Wochen-Bereich 17,5738
Marktkapitalisierung
Handelsende
15,90
Handelsbeginn
15,91
Letzte Trade
8
@
15.81
Letzter Handelszeitpunkt
23:30:01
Finanzvolumen
US$ 319.309
VWAP
15,8821
Durchschnittliches Volumen (3 Mio.)
US$ 345.003
Ausgegebene Aktien
5.289.675
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
-10,37
Gewinn pro Aktie (EPS)
-1,38
Erlöse (LTM)
858k
Nettogewinn (LTM)
-7,82M

Über Rallybio Corporation

Rallybio Corporation, a clinical-stage biotechnology company, engages in the development and commercialization of life-transforming therapies for patients suffering from severe and rare diseases. Its lead product candidate is the RLYB116, an inhibitor of complement component 5 (C5) to treat several ... Rallybio Corporation, a clinical-stage biotechnology company, engages in the development and commercialization of life-transforming therapies for patients suffering from severe and rare diseases. Its lead product candidate is the RLYB116, an inhibitor of complement component 5 (C5) to treat several diseases of complement dysregulation which has completed phase 1 trial; and RLYB332, a preclinical antibody, for the treatment of severe anemia with ineffective erythropoiesis and iron overload. The company has a strategic alliance with AbCellera to discover, develop, and commercialize novel antibody-based therapeutics for rare diseases, as well as collaboration agreement with Johnson & Johnson to provide therapeutic solutions for pregnant individuals at risk of fetal and neonatal alloimmune thrombocytopenia. Rallybio Corporation was founded in 2018 and is headquartered in New Haven, Connecticut. Mehr anzeigen

Sektor
Healthcare
Branche
Biotechnology & Life Sciences
Hauptsitz
New Haven, United States
Gegründet
2026
Rallybio Corporation is listed in the Healthcare sector of the NASDAQ with ticker RLYB. The last closing price for Rallybio was US$15,90. Over the last year, Rallybio shares have traded in a share price range of US$ 0,30 to US$ 17,5738.

Rallybio currently has 5.289.675 shares in issue. The market capitalisation of Rallybio is US$83,84 million. Rallybio has a price to earnings ratio (PE ratio) of -10.37.

RLYB Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.02-0.12602394454915.8716.515.765079315.91205678CS
41.6711.777150916814.1817.573813.87496615.97738276CS
126.8576.1111111111917.57387.926681613.63236942CS
2615.081958.441558440.7717.57380.55922307599.96364699CS
5215.52444767.936117940.325617.57380.39047361.70603458CS
1568.29109.6560846567.5617.57380.22015043792.01065181CS
2600.936.2332439678314.9225.780.22013437582.83774752CS

RLYB - Frequently Asked Questions (FAQ)

What is the current Rallybio Corporation share price?
The current share price of Rallybio Corporation is US$ 15,85
How many Rallybio Corporation shares are in issue?
Rallybio Corporation has 5.289.675 shares in issue
What is the market cap of Rallybio Corporation?
The market capitalisation of Rallybio Corporation is USD 83,84M
What is the 1 year trading range for Rallybio Corporation share price?
Rallybio Corporation has traded in the range of US$ 0,30 to US$ 17,5738 during the past year
What is the PE ratio of Rallybio Corporation?
The price to earnings ratio of Rallybio Corporation is -10,37
What is the cash to sales ratio of Rallybio Corporation?
The cash to sales ratio of Rallybio Corporation is 88,47
What is the registered address of Rallybio Corporation?
The registered address for Rallybio Corporation is 234 Church Street, New Haven, Connecticut, 06510
What is the Rallybio Corporation website address?
The website address for Rallybio Corporation is www.rallybio.com
Which industry sector does Rallybio Corporation operate in?
Rallybio Corporation operates in the Biotechnology & Life Sciences sector

RLYB Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen